0000919574-16-013777.txt : 20160622
0000919574-16-013777.hdr.sgml : 20160622
20160622151656
ACCESSION NUMBER: 0000919574-16-013777
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160621
FILED AS OF DATE: 20160622
DATE AS OF CHANGE: 20160622
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celator Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001327467
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202680869
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 303B COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 243-0123
MAIL ADDRESS:
STREET 1: 303B COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CDK ASSOCIATES, L.L.C.
CENTRAL INDEX KEY: 0001576081
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36179
FILM NUMBER: 161726547
BUSINESS ADDRESS:
STREET 1: C/O CAXTON CORPORATION
STREET 2: 731 ALEXANDER ROAD, BUILDING #2
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-419-1800
MAIL ADDRESS:
STREET 1: C/O CAXTON CORPORATION
STREET 2: 731 ALEXANDER ROAD, BUILDING #2
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAXTON CORP
CENTRAL INDEX KEY: 0001388551
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36179
FILM NUMBER: 161726548
BUSINESS ADDRESS:
STREET 1: 731 ALEXANDER ROAD
STREET 2: BUILDING 2
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-419-1800
MAIL ADDRESS:
STREET 1: 731 ALEXANDER ROAD
STREET 2: BUILDING 2
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kovner Bruce
CENTRAL INDEX KEY: 0001325713
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36179
FILM NUMBER: 161726549
MAIL ADDRESS:
STREET 1: C/O CAXTON ASSOCIATES
STREET 2: 500 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
p7191303.xml
OWNERSHIP DOCUMENT
X0306
4
2016-06-21
0
0001327467
Celator Pharmaceuticals Inc
CPXX
0001325713
Kovner Bruce
C/O CAXTON CORPORATION
731 ALEXANDER ROAD, BLDG. 2
PRINCETON
NJ
08540
0
0
0
1
See Remarks Section
0001388551
CAXTON CORP
731 ALEXANDER ROAD
BUILDING 2
PRINCETON
NJ
08540
0
0
0
1
See Remarks Section
0001576081
CDK ASSOCIATES, L.L.C.
C/O CAXTON CORPORATION
731 ALEXANDER ROAD, BLDG. 2
PRINCETON
NJ
08540
0
0
0
1
See Remarks Section
Common Stock
2016-06-21
4
G
0
88571
D
2157898
I
By CDK ASSOCIATES, LLC
Common Stock
2016-06-21
4
G
0
564222
D
1593676
I
By CDK ASSOCIATES, LLC
Common Stock
2016-06-21
4
G
0
564222
A
564222
I
See Footnote
Common Stock
2016-06-21
4
G
0
1926
D
1591750
I
By CDK ASSOCIATES, LLC
This transaction represents a gift/charitable donation effective June 21, 2016. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.
These securities are owned directly by CDK Associates, LLC, which is a reporting person. The securities directly owned by CDK Associates, LLC may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Each of Caxton Corporation and Bruce Kovner disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed to be an admission of the beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
These securities are owned directly by an investment entity wholly-owned by Bruce Kovner's family's charitable foundation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of the investment entity wholly-owned by the foundation, and (ii) Bruce Kovner, the co-chairman of the foundation and the chairman and sole shareholder of Caxton Corporation. Each of Caxton Corporation and Bruce Kovner disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed to be an admission of the beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
Scott Morenstein, a director of the Issuer, is an employee of Caxton Alternative Management LP, an affiliate of Caxton Corporation.
Bruce Kovner, By: /s/ Heath Weisberg, Attorney-in-Fact
2016-06-22
Caxton Corporation, By: /s/ Heath Weisberg, Chief Compliance Officer
2016-06-22
CDK Associates, LLC, By; Caxton Corporation, Manager, By: /s/ Heath Weisberg, Chief Compliance Officer
2016-06-22